BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

AEterna Zentaris 

1405 Boul Du Parc-technologique

Quebec  Quebec  G1P 4P5  Canada
Phone: 418-652-8525 Fax: 418-652-0881


SEARCH JOBS








 Company News
AEterna Zentaris (AEZS): Poster Presentation At American Association for Cancer Research Meeting Provides Rationale For New Therapeutic Opportunities In Oncology With Erk Inhibitors 4/9/2014 7:52:37 AM    More...
AEterna Zentaris (AEZS) To Present Poster On New Therapeutic Opportunities In Oncology With Erk Inhibitors At American Association for Cancer Research Meeting In San Diego 4/1/2014 12:44:17 PM    More...
AEterna Zentaris (AEZS) Announces Effectiveness Of $50 Million Shelf Registration Statement For "At-The-Market" Common Share Issuance Programs 3/30/2014 3:01:58 PM    More...
AEterna Zentaris (AEZS) Reports Fourth Quarter And Full-Year 2013 Financial And Operating Results 3/21/2014 9:22:47 AM    More...
AEterna Zentaris (AEZS) To Announce Fourth Quarter And Full-Year 2013 Financial And Operating Results On March 20, 2014 3/12/2014 6:56:23 AM    More...
AEterna Zentaris (AEZS): Article On Phase 2 Results For Zoptarelin Doxorubicin In Endometrial Cancer Published In The International Journal Of Gynecological Cancer 2/4/2014 10:06:12 AM    More...
AEterna Zentaris (AEZS): Presentations On Zoptarelin Doxorubicin And Disorazol Z Conjugates At Upcoming International Symposium On GnRH 2/3/2014 6:37:30 AM    More...
AEterna Zentaris (AEZS) Announces Closing Of $13.2 Million Public Offering Of Common Shares And Warrants 1/14/2014 10:29:34 AM    More...
AEterna Zentaris (AEZS) Announces Proposed Public Offering Of Common Shares And Warrants 1/9/2014 10:01:48 AM    More...
AEterna Zentaris (AEZS) Announces Pricing Of $13.2 Million Public Offering Of Common Shares And Warrants 1/9/2014 6:43:15 AM    More...
12345678910...

//-->